Clinical implementation of whole-genome array CGH as a first-tier test in 5080 pre and postnatal cases
Open Access
- 9 May 2011
- journal article
- Published by Springer Science and Business Media LLC in Molecular Cytogenetics
- Vol. 4 (1), 12
- https://doi.org/10.1186/1755-8166-4-12
Abstract
Array comparative genomic hybridization (CGH) is currently the most powerful method for detecting chromosomal alterations in pre and postnatal clinical cases. In this study, we developed a BAC based array CGH analysis platform for detecting whole genome DNA copy number changes including specific micro deletion and duplication chromosomal disorders. Additionally, we report our experience with the clinical implementation of our array CGH analysis platform. Array CGH was performed on 5080 pre and postnatal clinical samples from patients referred with a variety of clinical phenotypes. A total of 4073 prenatal cases (4033 amniotic fluid and 40 chorionic villi specimens) and 1007 postnatal cases (407 peripheral blood and 600 cord blood) were studied with complete concordance between array CGH, karyotype and fluorescence in situ hybridization results. Among 75 positive prenatal cases with DNA copy number variations, 60 had an aneuploidy, seven had a deletion, and eight had a duplication. Among 39 positive postnatal cases samples, five had an aneuploidy, 23 had a deletion, and 11 had a duplication. This study demonstrates the utility of using our newly developed whole-genome array CGH as first-tier test in 5080 pre and postnatal cases. Array CGH has increased the ability to detect segmental deletion and duplication in patients with variable clinical features and is becoming a more powerful tool in pre and postnatal diagnostics.Keywords
This publication has 34 references indexed in Scilit:
- Clinical application of whole-genome array CGH during prenatal diagnosis: Study of 25 selected pregnancies with abnormal ultrasound findings or apparently balanced structural aberrationsMolecular Cytogenetics, 2010
- Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesAmerican Journal of Human Genetics, 2010
- Validation and implementation of array comparative genomic hybridisation as a first line test in place of postnatal karyotyping for genome imbalanceMolecular Cytogenetics, 2010
- The array CGH and its clinical applicationsDrug Discovery Today, 2008
- Clinical Utility of Contemporary Molecular CytogeneticsAnnual Review of Genomics and Human Genetics, 2008
- Identification of chromosome abnormalities in subtelomeric regions by microarray analysis: A study of 5,380 casesAmerican Journal of Medical Genetics Part A, 2008
- Clinical Implementation of Chromosomal Microarray Analysis: Summary of 2513 Postnatal CasesPLOS ONE, 2007
- Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH arrayCancer Genetics and Cytogenetics, 2006
- Prenatal detection of unbalanced chromosomal rearrangements by array CGHJournal of Medical Genetics, 2005
- Genomic microarrays in human genetic disease and cancerHuman Molecular Genetics, 2003